Sulbactam–durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia -associated Fitz–Hugh–Curtis syndrome
Antimicrobial Agents and Chemotherapy · 01.07.2026 · 70 (7)
DOI: 10.1128/aac.01542-25 ↗Kurz gefasst
Fallbericht in der Zeitschrift Antimicrobial Agents and Chemotherapy, erschienen am 01.07.2026. Verfasst von Bhavita Gaglani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine and Anesthesiology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA. Hauptthemen laut MEDLINE: Anti-Bacterial Agents, Cephalosporins, Sulbactam, Burkholderia Infections. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIH HHS, National Institutes of Health.
Abstract (Originalsprache)
A 50-year-old woman with cystic fibrosis (CF) and lung transplantation developed persistent deep abscesses due to multidrug-resistant (MDR) Burkholderia cenocepacia, unresponsive to multiple antibiotics and surgeries. Combination therapy with sulbactam–durlobactam (SUL-DUR) and cefiderocol (FDC) along with surgical interventions led to clinical and radiographic stability. This report of a successful sulbactam–durlobactam and cefiderocol treatment highlights this targeted β-lactam-β-lactamase inhibitor combination as an option for refractory B. cepacia complex (BCC) infections.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine and Anesthesiology, Wake Forest School of Medicine, Winston Salem, North Carolina, USA.
- Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
- Institute of Global Health & Infectious Diseases, University of North Carolina, Chapel Hill, North Carolina, USA.
- Department of Radiology, Molecular Imaging and Therapeutics, University of North Carolina, Chapel Hill, North Carolina, USA.
- Division of Abdominal Transplant, Department of Surgery, University of North Carolina, Chapel Hill, North Carolina, USA.
- Research Service, Louis Stokes Cleveland Department of Veterans Affairs Medical Center, Cleveland, Ohio, USA.
ORCID-Profile: Bhavita Gaglani, Robert A Bonomo, David van Duin
Förderung
- NIH HHS
- National Institutes of Health
Zitieren
APA
Gaglani, B., Andermann, T. M., Wate, C., Oldan, J., Desai, C. S., Marshall, S. H., Bonomo, R. A., Coakley, R., van Duin, D., & Lachiewicz, A. (2026). Sulbactam–durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia -associated Fitz–Hugh–Curtis syndrome. Antimicrobial Agents and Chemotherapy, 70(7). https://doi.org/10.1128/aac.01542-25
Vancouver
Gaglani B, Andermann TM, Wate C, Oldan J, Desai CS, Marshall SH, et al. Sulbactam–durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia -associated Fitz–Hugh–Curtis syndrome. Antimicrobial Agents and Chemotherapy. 2026;70(7). doi:10.1128/aac.01542-25
BibTeX
@article{Gaglani2026,
author = {Gaglani, Bhavita and Andermann, Tessa M and Wate, Claire and Oldan, Jorge and Desai, Chirag S and Marshall, Steven H and Bonomo, Robert A and Coakley, Ray and van Duin, David and Lachiewicz, Anne},
title = {Sulbactam–durlobactam and cefiderocol combination treatment of Burkholderia cenocepacia -associated Fitz–Hugh–Curtis syndrome},
journal = {Antimicrobial Agents and Chemotherapy},
year = {2026},
volume = {70},
number = {7},
doi = {10.1128/aac.01542-25}
}
EUVIMED